167 related articles for article (PubMed ID: 12614867)
21. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.
Jacobsson SO; Wallin T; Fowler CJ
J Pharmacol Exp Ther; 2001 Dec; 299(3):951-9. PubMed ID: 11714882
[TBL] [Abstract][Full Text] [Related]
22. Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB(2) cannabinoid, as potential ligands for the cannabinoid receptors.
Lambert DM; DiPaolo FG; Sonveaux P; Kanyonyo M; Govaerts SJ; Hermans E; Bueb J; Delzenne NM; Tschirhart EJ
Biochim Biophys Acta; 1999 Sep; 1440(2-3):266-74. PubMed ID: 10521710
[TBL] [Abstract][Full Text] [Related]
23. Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway.
Sancho R; Calzado MA; Di Marzo V; Appendino G; Muñoz E
Mol Pharmacol; 2003 Feb; 63(2):429-38. PubMed ID: 12527815
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological properties of rat brain fatty acid amidohydrolase in different subcellular fractions using palmitoylethanolamide as substrate.
Tiger G; Stenström A; Fowler CJ
Biochem Pharmacol; 2000 Mar; 59(6):647-53. PubMed ID: 10677581
[TBL] [Abstract][Full Text] [Related]
25. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
Jacobsson SO; Fowler CJ
Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
[TBL] [Abstract][Full Text] [Related]
26. The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase.
De Petrocellis L; Harrison S; Bisogno T; Tognetto M; Brandi I; Smith GD; Creminon C; Davis JB; Geppetti P; Di Marzo V
J Neurochem; 2001 Jun; 77(6):1660-3. PubMed ID: 11413249
[TBL] [Abstract][Full Text] [Related]
27. Multiple actions of anandamide on neonatal rat cultured sensory neurones.
Evans RM; Scott RH; Ross RA
Br J Pharmacol; 2004 Apr; 141(7):1223-33. PubMed ID: 15023857
[TBL] [Abstract][Full Text] [Related]
28. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism.
De Petrocellis L; Bisogno T; Maccarrone M; Davis JB; Finazzi-Agro A; Di Marzo V
J Biol Chem; 2001 Apr; 276(16):12856-63. PubMed ID: 11278420
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
[TBL] [Abstract][Full Text] [Related]
30. Protein kinase C activation potentiates gating of the vanilloid receptor VR1 by capsaicin, protons, heat and anandamide.
Vellani V; Mapplebeck S; Moriondo A; Davis JB; McNaughton PA
J Physiol; 2001 Aug; 534(Pt 3):813-25. PubMed ID: 11483711
[TBL] [Abstract][Full Text] [Related]
31. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
Amorós I; Barana A; Caballero R; Gómez R; Osuna L; Lillo MP; Tamargo J; Delpón E
J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
[TBL] [Abstract][Full Text] [Related]
32. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
Di Marzo V; Breivogel CS; Tao Q; Bridgen DT; Razdan RK; Zimmer AM; Zimmer A; Martin BR
J Neurochem; 2000 Dec; 75(6):2434-44. PubMed ID: 11080195
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and characterization of a fluorescent substrate for the N-arachidonoylethanolamine (anandamide) transmembrane carrier.
Muthian S; Nithipatikom K; Campbell WB; Hillard CJ
J Pharmacol Exp Ther; 2000 Apr; 293(1):289-95. PubMed ID: 10734181
[TBL] [Abstract][Full Text] [Related]
34. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus.
Craib SJ; Ellington HC; Pertwee RG; Ross RA
Br J Pharmacol; 2001 Sep; 134(1):30-7. PubMed ID: 11522594
[TBL] [Abstract][Full Text] [Related]
35. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
[TBL] [Abstract][Full Text] [Related]
36. Anandamide is a partial agonist at native vanilloid receptors in acutely isolated mouse trigeminal sensory neurons.
Roberts LA; Christie MJ; Connor M
Br J Pharmacol; 2002 Oct; 137(4):421-8. PubMed ID: 12359623
[TBL] [Abstract][Full Text] [Related]
37. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide.
Facci L; Dal Toso R; Romanello S; Buriani A; Skaper SD; Leon A
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3376-80. PubMed ID: 7724569
[TBL] [Abstract][Full Text] [Related]
38. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
Ho WS; Barrett DA; Randall MD
Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
[TBL] [Abstract][Full Text] [Related]
39. Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide.
Sprague J; Harrison C; Rowbotham DJ; Smart D; Lambert DG
Eur J Pharmacol; 2001 Jul; 423(2-3):121-5. PubMed ID: 11448475
[TBL] [Abstract][Full Text] [Related]
40. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
